pharmaceuticals

Short Sellers Shy Away From Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

20 Biopharma Stocks for Huge Upside Potential in 2020

Now that 2020 is well underway, investors are already moving on from just thinking about how wonderful the stock market performance was in 2019 and how wonderful stocks have been ...
Read Full Story »

How This Dermira Acquisition Will Round Out Eli Lilly

Dermira Inc. (NASDAQ: DERM) shares made a handy gain to close out the week after it was announced that Eli Lilly and Co. (NYSE: LLY) would be acquiring the firm. ...
Read Full Story »

Why This Study Is a Big Step Forward in the Fight Against Diabetes

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults with Type 1 diabetes mellitus. Results from ...
Read Full Story »

Why This PNH Study Could Set the Standard for Treatment

Apellis Pharmaceuticals Inc. (NASDAQ: APLS) shares jumped on Tuesday after the firm announced positive results from its late-stage study in adults with paroxysmal nocturnal hemoglobinuria (PNH). Specifically, the data came ...
Read Full Story »

The Top Biotech ETFs to Watch in 2020

Companies in the biotech industry face an incredible amount of risk while getting their drugs to market. A study coming back negative or a candidate not being approved could crush ...
Read Full Story »

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want ...
Read Full Story »

The Top Biopharma Events to Watch in 2020

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

AstraZeneca’s FDA Nod Could Be Big

AstraZeneca PLC (NYSE: AZN) has announced that the U.S. Food and Drug Administration (FDA) has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer. Specifically, the approval ...
Read Full Story »

Big Pharma Short Sellers Get Selective

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The Top Biopharma Calendar Events to Watch Going Into 2020

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk and scrutiny with regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »

The First Ebola Vaccine Has Been Approved in the US

NewLink Genetics Corp. (NASDAQ: NLNK) and Merck & Co. Inc. (NYSE: MRK) shares made handy gains on Friday after it was announced that the U.S. Food and Drug Administration (FDA) ...
Read Full Story »

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Bristol-Myers Squibb Co. (NYSE: BMY) may be one of the better alternatives for pharmaceutical and biohealth investors in 2020. Independent research firm Argus, which has none of the traditional potential ...
Read Full Story »

Big Pharma Short Sellers Grow More Selective

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »